£125K
The pre-seed investment from LYVA Labs will accelerate product development and commercialisation.
"LYVA Labs is delighted to back Sam, Martin and Richard in their mission to help reduce the number of people dying from blood cancer by providing the technology to allow more rapid diagnosis which will enable earlier treatment for the condition."

